| BSE: 507789 | Sector: Health care |
| NSE: JAGSNPHARM | ISIN Code: INE048B01027 |
| BSE 00:00 | 20 Mar | 27.55 |
-0.05 (-0.18%) |
OPEN
29.50 |
HIGH
29.50 |
LOW
27.10 |
| NSE 00:00 | 20 Mar | 27.75 |
0 (0.00%) |
OPEN
28.00 |
HIGH
28.00 |
LOW
27.30 |
| OPEN | 29.50 |
| PREVIOUS CLOSE | 27.60 |
| VOLUME | 1272 |
| 52-Week high | 35.00 |
| 52-Week low | 22.20 |
| P/E | 23.96 |
| Mkt Cap.(Rs cr) | 72 |
| Buy Price | 27.20 |
| Buy Qty | 1000.00 |
| Sell Price | 30.00 |
| Sell Qty | 2.00 |
11.23 am | 19 Mar 2019 | Business Standard
In the last five sessions, the index has been hovering at 200-days moving average (DMA) located around 9230, as per daily chart. A major trigger for a...
11.23 am | 19 Mar 2019 | Business Standard
In the last five sessions, the index has been hovering at 200-days moving average (DMA) located around 9230, as per daily chart. A major trigger for a...
9.57 am | 18 Mar 2019 | Business Standard
The facility may be subject to regulatory or administrative action and the US FDA may withhold approval of any pending applications or supplements in ...
9.33 pm | 16 Mar 2019 | Press Trust of India
'Official Action Indicated' means approvals of pending applications or supplements from this site maybe withheld
1.09 am | 15 Mar 2019 | Business Standard
The company has slipped to being the seventh-largest pharma company in terms of market cap
7.39 am | 14 Mar 2019 | Business Standard
Here's a look at the top stocks that may remain in focus today -
10.19 pm | 13 Mar 2019 | Business Standard
Torrent has successfully gained volume share and demonstrated its ability to take price increases
11.35 am | 13 Mar 2019 | Business Standard
The NPPA website notes that the amount still under litigation is around Rs 4,084.05 crore
6.59 am | 13 Mar 2019 | Business Standard
Nifty outlook and top trading ideas by Vaishali Parekh, research analyst - technical research at Prabhudas Lilladher.
11.01 pm | 12 Mar 2019 | Business Standard
This is the first major launch by Piramal Pharma Solutions through a partner
7.21 pm | 11 Mar 2019 | Business Standard
If the possession has already been handed over, promoter will not alienate, transfer or create third-party encumbrance of properties and must ensure f...
4.00 pm | 11 Mar 2019 | Business Standard
Medicine is a therapeutic equivalent of Plaquenil tablets of Concordia Pharma of US
11.35 am | 11 Mar 2019 | Business Standard
The pharmaceutical company's stock has rallied 20 per cent in the past four trading days, as compared to 2 per cent rise in the S&P BSE Sensex
12.15 am | 10 Mar 2019 | Business Standard
The management has said AHLL's revenue has been growing well
4.26 pm | 8 Mar 2019 | Business Standard
This potential acquisition of Rising's assets would transform Shore Suven Pharma into a strong US generic pharmaceutical company
2.51 pm | 8 Mar 2019 | Business Standard
The first half of calendar year 2019 (H1CY19), it believes, will be a difficult phase for the markets due to continued election uncertainty, potential...
1.56 pm | 8 Mar 2019 | Business Standard
In past one month, Ipca Labs outperformed the market by surging 25 per cent, against a marginal 0.1 per cent rise in the S&P BSE Sensex
12.37 pm | 8 Mar 2019 | Business Standard
The stock rallied 10 per cent to Rs 114 in intra-day trade on Friday
10.09 pm | 6 Mar 2019 | Business Standard
Riva's appointment as CEO of Glenmark's innovation business is effective from April 2.
10.13 am | 6 Mar 2019 | Business Standard
The pharma company had reported a nearly four-fold jump in its consolidated net profit at Rs 1,241.85 crore for the third quarter of financial year 20...
